Topical cidofovir‐related acute kidney injury in a kidney transplant recipient
2022; Wiley; Volume: 36; Issue: 11 Linguagem: Inglês
10.1111/ctr.14824
ISSN1399-0012
AutoresArzu Velioğlu, Eren Erdogan, Elif Tükenmez Tigen, Züleyha Özgen, Serhan Tuğlular,
Tópico(s)Virus-based gene therapy research
ResumoClinical TransplantationVolume 36, Issue 11 e14824 LETTER TO THE EDITOR Topical cidofovir-related acute kidney injury in a kidney transplant recipient Arzu Velioglu, Corresponding Author Arzu Velioglu [email protected] orcid.org/0000-0001-9750-7585 Division of Nephrology, Department of Internal Medicine, School of Medicine, Marmara University, Istanbul, Turkey Correspondence Arzu Velioglu, Marmara University Pendik Egitim Arastirma HAstanesi, Fevzi Cakmak Mah. Muhsin Yazicioglu Cad. No: 10 Ust Kaynarca-Pendik/Istanbul, Turkey. Email: [email protected]Search for more papers by this authorEren Erdogan, Eren Erdogan School of Medicine, Marmara University, Istanbul, TurkeySearch for more papers by this authorElif Tigen, Elif Tigen Department of Infectious Disease, School of Medicine, Marmara University, Istanbul, TurkeySearch for more papers by this authorZüleyha Ozgen, Züleyha Ozgen Department of Dermatology, School of Medicine, Marmara University, Istanbul, TurkeySearch for more papers by this authorSerhan Tuglular, Serhan Tuglular Division of Nephrology, Department of Internal Medicine, School of Medicine, Marmara University, Istanbul, TurkeySearch for more papers by this author Arzu Velioglu, Corresponding Author Arzu Velioglu [email protected] orcid.org/0000-0001-9750-7585 Division of Nephrology, Department of Internal Medicine, School of Medicine, Marmara University, Istanbul, Turkey Correspondence Arzu Velioglu, Marmara University Pendik Egitim Arastirma HAstanesi, Fevzi Cakmak Mah. Muhsin Yazicioglu Cad. No: 10 Ust Kaynarca-Pendik/Istanbul, Turkey. Email: [email protected]Search for more papers by this authorEren Erdogan, Eren Erdogan School of Medicine, Marmara University, Istanbul, TurkeySearch for more papers by this authorElif Tigen, Elif Tigen Department of Infectious Disease, School of Medicine, Marmara University, Istanbul, TurkeySearch for more papers by this authorZüleyha Ozgen, Züleyha Ozgen Department of Dermatology, School of Medicine, Marmara University, Istanbul, TurkeySearch for more papers by this authorSerhan Tuglular, Serhan Tuglular Division of Nephrology, Department of Internal Medicine, School of Medicine, Marmara University, Istanbul, TurkeySearch for more papers by this author First published: 18 September 2022 https://doi.org/10.1111/ctr.14824Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. REFERENCES 1Workowski KA. Centers for disease control and prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2015; 61(suppl 8): S759- S762. 2Kralund HH, Broesby-Olsen S, Bistrup C, Lorentzen HF. Substantial effect of topical cidofovir 1% on recalcitrant warts in a renal-transplanted adolescent: a case report. Transplantation. 2011; 91(7): e52- e54. doi:10.1097/TP.0b013e31820f08d0 3Das BB, Anton K, Knox L, Jarin J, Sue PK. Successful treatment of giant condyloma in a pediatric heart transplant recipient with topical cidofovir. Transpl Infect Dis. 2018; 20(6):e12989. doi:10.1111/tid.12989 4Bienvenu B, Martinez F, Devergie A, et al. Topical use of cidofovir induced acute renal failure. Transplantation. 2002; 73(4): 661- 662. doi:10.1097/00007890-200202270-00033 5Saunders IM, Lahoti A, Chemaly RF, Trevino C, Westmoreland M, Hosing C. Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections. J Oncol Pharm Pract. 2016; 22(2): 325- 331. doi:10.1177/1078155214560921 6Cundy KC, Lynch G, Lee WA. Bioavailability and metabolism of cidofovir following topical administration to rabbits. Antiviral Res. 1997; 35(2): 113- 122. doi:10.1016/s0166-3542(97)00022-3 7Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30(2): 239- 245. doi:10.1038/clpt.1981.154 8Khokhar NZ, Altman JK, Platanias LC. Emerging roles for mammalian target of rapamycin inhibitors in the treatment of solid tumors and hematological malignancies. Curr Opin Oncol. 2011; 23: 578- 586. Citing Literature Volume36, Issue11November 2022e14824 ReferencesRelatedInformation
Referência(s)